Fig. 1From: Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancerVHH or nanobodies are derived from camel heavy chain antibodies. These nanobodies are labeled by various agents and are able to detect specific antigens in breast cancer tissuesBack to article page